Renaissance Technologies (RenTech)'s LONA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 75,147 shares of LeonaBio, Inc. (LONA) worth $568,863, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in LONA, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 23,223 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s LeonaBio (LONA) Holding Value Over Time
Track share changes against reported price movement
Quarterly LeonaBio (LONA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +23,223 | Add 44.72% | 75,147 | $7.57 |
| Q3 2025 | +51,924 | New Buy | 51,924 | $4.14 |
Renaissance Technologies (RenTech)'s LeonaBio Investment FAQs
Renaissance Technologies (RenTech) first purchased LeonaBio, Inc. (LONA) in Q3 2025, acquiring 51,924 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held LeonaBio, Inc. (LONA) for 2 quarters since Q3 2025.
Renaissance Technologies (RenTech)'s largest addition to LeonaBio, Inc. (LONA) was in Q3 2025, adding 51,924 shares worth $214,965.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 75,147 shares of LeonaBio, Inc. (LONA), valued at approximately $568,863.
As of the Q4 2025 filing, LeonaBio, Inc. (LONA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in LeonaBio, Inc. (LONA) was 75,147 shares, as reported at the end of Q4 2025.